Login / Signup

Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy.

Ajai ChariDan T VoglSundar JagannathJagoda JasielecThaddeus J UngerAndrew DeCastroJatin ShahMichael KauffmanSharon ShachamAndrzej J Jakubowiak
Published in: British journal of haematology (2020)
Keyphrases
  • cell therapy
  • stem cells
  • mesenchymal stem cells
  • multiple myeloma